The dementia drug rivastigmine may reduce the risk of falls in patients with Parkinson’s disease by improving gait stability, findings from the phase II ReSponD trial show.
from Dementia Big http://ift.tt/1JWQVCh via alcoholic dementia
http://ift.tt/1PEgaWs
No comments:
Post a Comment